Related Experiment Video
Updated: May 9, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Developmental origins of colon smooth muscle dysfunction in IBS-like rats
Qingjie Li1, John H Winston, Sushil K Sarna
1Div. of Gastroenterology, The Univ. of Texas Medical Branch at Galveston, 8.102 Medical Research Bldg., Galveston, TX 77555-1083. sksarna@utmb.edu.
Insights
Neonatal colon inflammation in rats increases VIP, altering gene expression in smooth muscle. This epigenetic change may explain adult smooth muscle dysfunction and irritable bowel syndrome (IBS) symptoms.
Area of Science:
- Gastroenterology
- Molecular Biology
- Epigenetics
Background:
- Irritable bowel syndrome (IBS) is linked to early-life stress.
- Colonic smooth muscle dysfunction contributes to IBS.
- Cellular mechanisms underlying this dysfunction require elucidation.
Purpose of the Study:
- To investigate the cellular and epigenetic mechanisms of colonic smooth muscle dysfunction following neonatal inflammation in rats.
- To determine the role of vasoactive intestinal peptide (VIP) and epigenetic modifications in regulating Cav1.2b channel expression.
Main Methods:
- Neonatal rats were induced with colonic inflammation using 2,4,6-trinitrobenzene sulfonic acid.
- Colonic smooth muscle function and gene expression (Cav1.2b, VIP mRNA) were assessed in adulthood.
- Epigenetic modifications (histone acetylation, HDAC3 interaction) at the Cav1.2b promoter were analyzed.
Main Results:
- Neonatal inflammation led to increased Cav1.2b channel subunit and VIP mRNA in adult rat colonic smooth muscle.
- Reduced histone deacetylase 3 (HDAC3) interaction with the Cav1.2b promoter increased histone H3 lysine 9 (H3K9) acetylation.
- VIP treatment mimicked these epigenetic changes, suggesting a role in regulating gene transcription.
Conclusions:
- Neonatal inflammation upregulates VIP, inducing epigenetic changes at the Cav1.2b promoter, leading to smooth muscle dysfunction.
- Early-life inflammatory insults may contribute to adult-onset IBS, particularly diarrhea-predominant IBS.
- This study reveals a novel epigenetic mechanism linking early-life inflammation to gut motility disorders.
Abstract:
Epidemiological studies show that subsets of adult and pediatric patients with irritable bowel syndrome (IBS) have prior exposures to psychological or inflammatory stress. We investigated the cellular mechanisms of colonic smooth muscle dysfunction in adult rats subjected to neonatal inflammation. Ten-day-old male rat pups received 2,4,6-trinitrobenzene sulfonic acid to induce colonic inflammation. Colonic circular smooth muscle strips were obtained 6 to 8 wk later. We found that about half of the neonate pups subjected to inflammatory insult showed a significant increase in expression of the pore-forming α1C-subunit of Cav1.2b channels in adult life. These were the same rats in whom Vip mRNA increased in the colon muscularis externae. Additional experiments showed reduced interaction of histone deacetylase (HDAC) 3 with α1C1b promoter that increased the acetylation of histone H3 lysine 9 (H3K9) in the core promoter region. Vasoactive intestinal peptide (VIP) treatment of naïve muscularis externae swiftly recruited CREB-binding protein (CBP) to the α1C1b promoter and dissociated HDAC3 from this region to initiate transcription. The CBP interaction with the α1C1b promoter was transient, but the dissociation of HDAC3 persisted to sustain H3K9 hyperacetylation and increase in transcription. Intraperitoneal treatment of adult naïve rats with butyrate mimicked the effects of neonatal colon inflammation. We concluded that neonatal inflammation upregulates VIP in the colon muscularis externae, which modulates epigenetic events at the α1C1b promoter to activate α1C1b gene transcription. Inflammatory insult in early life may be one of the etiologies of smooth muscle dysfunction in adult life, which contributes to the altered motility function in patients with diarrhea-predominant IBS.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: